trending Market Intelligence /marketintelligence/en/news-insights/trending/MAr22mitf_Mgtr5jKjq8SA2 content esgSubNav
In This List

ContraVir Pharmaceuticals gets Nasdaq noncompliance notice

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


ContraVir Pharmaceuticals gets Nasdaq noncompliance notice

ContraVir Pharmaceuticals Inc. said it was evaluating its options after its stocks fell out of compliance with Nasdaq's minimum bid listing requirement of $1 per share.

The company has until Dec. 4 to regain compliance and may be eligible for a further extension.

The notice has no immediate effect on the company's listing on the stock market.